We investigated and evaluated post-irradiation survival in cyclooxygenase-2-deficient (COX-2 KO) mice. Thirty-day survival following exposure of COX-2 KO mice to a lethal dose of 8.5 Gy of gamma-rays was observed to be statistically significantly lower in both males and females, as well as when the sexes were merged, in comparisons with their wild-type counterparts. These findings were related to the previous observations concerning the detrimental influence of the COX-2 genetic disruption on hematopoiesis in sublethally irradiated mice. Deteriorated post-irradiation survival of COX-2 KO mice confirmed the previously anticipated conclusion regarding negative influence of the antiinflammatory action of COX-2 deficiency under the conditions of exposure of the animals to ionizing radiation.

Department of Cell Biology and Radiobiology Institute of Biophysics of the Czech Academy of Sciences Brno Czech Republic

Zobrazit více v PubMed

ALPEN EL: Radiation Biophysics. Academic Press, San Diego, London, Boston, New York, Sydney, Tokyo, Toronto, 1990, 259 p.

BJARNASON I, SCARPIGNATO C, HOLMGREN E, OLSZEWSKI M, RAINSFORD KD, LANAS A: Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology 154: 500–514, 2018. PubMed

FITZGERALD GA, PATRONO C : The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345: 433–442, 2001. PubMed

HEKIN N, CETIN Z, NIKITAKI Z, CORT A, SAYGILI I: Radiation triggering immune response and inflammation. Cancer Lett 368: 156–163, 2015. PubMed

HOFER M, HOFEROVÁ Z, DUŠEK L, SOUČEK K, GRUZDEV A: Hematological profile of untreated or ionizing radiation-exposed cyclooxygenase-2-deficient mice. Physiol Res 66: 673–676, 2017. PubMed PMC

HOFER M, POSPÍŠIL M, DUŠEK L, HOFEROVÁ Z, KOMŮRKOVÁ D: Agonist of the adenosine A3 receptor, IB-MECA, and inhibitor of cyclooxygenase-2, meloxicam, given alone or in a combination early after total body irradiation enhance survival of γ-irradiated mice. Radiat Environ Biophys 53: 211–215, 2014. PubMed

HOFER M, POSPÍŠIL M, DUŠEK L, HOFEROVÁ Z, WEITEROVÁ L: A single dose of an inhibitor of cyclooxygenase 2, meloxicam, administered shortly after irradiation increases survival of lethally irradiated mice. Radiat Res 176: 269–272, 2011. PubMed

HOFER M, POSPÍŠIL M, HOLÁ J, VACEK A, ŠTREITOVÁ D, ZNOJIL V: Inhibition of cyclooxygenase 2 in mice increases production of G-CSF and induces radioprotection. Radiat Res 170: 566–571, 2008. PubMed

MORHAM SG, LANGENBACH R, LOFTIN CD, TIANO HF, VOULOUMANOS N, JENNETTE JC, MAHLER JF, KLUCKMAN KD, LEDFORD A, LEE CA, SMITHIES O: Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473–482, 1995. PubMed

PATRIGNANI P, PATRONO C : Cyclooxygenase inhibitors: From pharmacology to clinical read-outs. Biochim Biophys Acta 1851: 422–432, 2015. PubMed

RAYAR AM, LAGARDE N, FERROUD C, ZAGURY JF, MONTES M, VEITIA MS: Update on COX-2 selective inhibitors: Chemical classification, side effects and their use in cancers and neuronal diseases. Curr Topics Med Chem 17: 2935–2956, 2017. PubMed

Brief Story on Prostaglandins, Inhibitors of their Synthesis, Hematopoiesis, and Acute Radiation Syndrome